Clinical Trial Update: A Multicentre randomiSed Controlled TRial of IntraVEnous Immunoglobulin Versus Standard Therapy for Transverse Myelitis [Phase 3]

View source ↗

Summary

A Phase 3 multicenter randomized trial comparing intravenous immunoglobulin to standard therapy for transverse myelitis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica
• Transverse Myelitis

Drugs mentioned

• Intravenous Immunoglobulin (IVIG)

Snippet

Sponsor: Guy's and St Thomas' NHS Foundation Trust | Conditions: Myelitis, Transverse, Neuromyelitis Optica | Phase 3 | Status: TERMINATED